Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia
Crossref DOI link: https://doi.org/10.1007/s00432-017-2517-0
Published Online: 2017-09-11
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jiang, Qian http://orcid.org/0000-0001-7131-0522
Wang, Haibo
Yu, Lu
Gale, Robert Peter
Funding for this research was provided by:
National Natural Science Foundation of China (No. 81370637)
License valid from 2017-09-11